27743686|t|Effect of alpha lipoic acid on in vitro development of bovine secondary preantral follicles
27743686|a|The present study aimed to evaluate the in vitro effect of alpha lipoic acid (ALA) addition to the culture medium on the development of the bovine secondary preantral follicles. Bovine secondary preantral follicles were collected and divided into two groups depending on their size (80-100 μm and 100-110 μm). They were cultured in vitro for 15 days (D) using different media including at three different doses of ALA. The genes expression levels of follicle-stimulating hormone beta-subunit (FSHR), insulin-like growth factor (IGF-1), Activin, luteinizing hormone/choriogonadotropin receptor, bone morphogenetic protein receptor type IA, transforming growth factor beta receptor 1, growth differentiation factor 9, BCL2-associated X protein (BAX), and C-Myc were studied using real-time polymerase chain reaction. The protein expression levels of FSHR, IGF-1, and BAX were measured using Western blot analysis. The results of the present work revealed that in vitro addition of ALA - induced significant increase in the growth and development of secondary preantral follicles throughout the culture period as compared to control. The FSHR, IGF-1, luteinizing hormone/choriogonadotropin receptor, bone morphogenetic protein receptor type IA, transforming growth factor beta receptor 1, growth differentiation factor 9, and Activin A genes were upregulated in ALA - treated follicles as compared to the control. On contrary, preapoptotic genes BAX and C-Myc were downregulated in treated follicles compared to control ones. The protein levels of FSHR and IGF-1 were highly expressed in treated follicles compared to control; however, BAX protein was downregulated in the treated follicles groups. The addition of ALA to the culture medium enhances secondary preantral follicles development and growth.
27743686	0	9	Effect of	T080	C1704420
27743686	10	27	alpha lipoic acid	T109,T121,T127	C0023791
27743686	31	39	in vitro	T080	C1533691
27743686	40	51	development	T040	C0678723
27743686	55	61	bovine	T015	C3667982
27743686	62	91	secondary preantral follicles	T023	C0737234
27743686	104	109	study	T062	C2603343
27743686	119	127	evaluate	T058	C0220825
27743686	132	140	in vitro	T080	C1533691
27743686	141	150	effect of	T080	C1704420
27743686	151	168	alpha lipoic acid	T109,T121,T127	C0023791
27743686	170	173	ALA	T109,T121,T127	C0023791
27743686	191	205	culture medium	T130	C0010454
27743686	213	224	development	T040	C0678723
27743686	232	238	bovine	T015	C3667982
27743686	239	268	secondary preantral follicles	T023	C0737234
27743686	270	276	Bovine	T015	C3667982
27743686	277	306	secondary preantral follicles	T023	C0737234
27743686	312	321	collected	T169	C1516698
27743686	326	333	divided	T169	C0332849
27743686	343	349	groups	T078	C0441833
27743686	369	373	size	T082	C0456389
27743686	421	429	in vitro	T080	C1533691
27743686	462	467	media	T130	C0010454
27743686	497	502	doses	T081	C0178602
27743686	506	509	ALA	T109,T121,T127	C0023791
27743686	515	531	genes expression	T045	C0017262
27743686	532	538	levels	T080	C0441889
27743686	542	583	follicle-stimulating hormone beta-subunit	T028	C1414828
27743686	585	589	FSHR	T028	C1414828
27743686	592	618	insulin-like growth factor	T028	C1334089
27743686	620	625	IGF-1	T028	C1334089
27743686	628	635	Activin	T028	C0017337
27743686	637	684	luteinizing hormone/choriogonadotropin receptor	T028	C1416843
27743686	686	729	bone morphogenetic protein receptor type IA	T028	C1332430
27743686	731	773	transforming growth factor beta receptor 1	T028	C1424583
27743686	775	806	growth differentiation factor 9	T028	C1333668
27743686	808	833	BCL2-associated X protein	T028	C0812198
27743686	835	838	BAX	T028	C0812198
27743686	845	850	C-Myc	T028	C0079068
27743686	870	905	real-time polymerase chain reaction	T063	C1709846
27743686	911	929	protein expression	T045	C1171362
27743686	930	936	levels	T080	C0441889
27743686	940	944	FSHR	T116,T192	C0034806
27743686	946	951	IGF-1	T116,T123	C0021665
27743686	957	960	BAX	T116,T123	C0219474
27743686	981	1002	Western blot analysis	T059	C0949466
27743686	1008	1015	results	T034	C1254595
27743686	1050	1058	in vitro	T080	C1533691
27743686	1071	1074	ALA	T109,T121,T127	C0023791
27743686	1077	1084	induced	T169	C0205263
27743686	1085	1096	significant	T078	C0750502
27743686	1097	1119	increase in the growth	T042	C1155901
27743686	1124	1135	development	T040	C0678723
27743686	1139	1168	secondary preantral follicles	T023	C0737234
27743686	1184	1191	culture	T059	C0430400
27743686	1192	1198	period	T079	C1948053
27743686	1202	1210	compared	T052	C1707455
27743686	1214	1221	control	T096	C0009932
27743686	1227	1231	FSHR	T028	C1414828
27743686	1233	1238	IGF-1	T028	C1334089
27743686	1240	1287	luteinizing hormone/choriogonadotropin receptor	T028	C1416843
27743686	1289	1332	bone morphogenetic protein receptor type IA	T028	C1332430
27743686	1334	1376	transforming growth factor beta receptor 1	T028	C1424583
27743686	1378	1409	growth differentiation factor 9	T028	C1333668
27743686	1415	1430	Activin A genes	T028	C0017337
27743686	1436	1447	upregulated	T044	C0041904
27743686	1451	1454	ALA	T109,T121,T127	C0023791
27743686	1457	1464	treated	T169	C1522326
27743686	1465	1474	follicles	T023	C0737234
27743686	1478	1486	compared	T052	C1707455
27743686	1494	1501	control	T096	C0009932
27743686	1516	1534	preapoptotic genes	T028	C0017337
27743686	1535	1538	BAX	T028	C0812198
27743686	1543	1548	C-Myc	T028	C0079068
27743686	1554	1567	downregulated	T044	C0013081
27743686	1571	1578	treated	T169	C1522326
27743686	1579	1588	follicles	T023	C0737234
27743686	1589	1597	compared	T052	C1707455
27743686	1601	1608	control	T096	C0009932
27743686	1619	1633	protein levels	T034	C0428479
27743686	1637	1641	FSHR	T116,T192	C0034806
27743686	1646	1651	IGF-1	T116,T123	C0021665
27743686	1664	1673	expressed	T045	C1171362
27743686	1677	1684	treated	T169	C1522326
27743686	1685	1694	follicles	T023	C0737234
27743686	1695	1703	compared	T052	C1707455
27743686	1707	1714	control	T096	C0009932
27743686	1725	1736	BAX protein	T116,T123	C0219474
27743686	1741	1754	downregulated	T044	C0013081
27743686	1762	1769	treated	T169	C1522326
27743686	1770	1779	follicles	T023	C0737234
27743686	1780	1786	groups	T078	C0441833
27743686	1804	1807	ALA	T109,T121,T127	C0023791
27743686	1815	1829	culture medium	T130	C0010454
27743686	1830	1838	enhances	T052	C2349975
27743686	1839	1868	secondary preantral follicles	T023	C0737234
27743686	1869	1880	development	T040	C0678723
27743686	1885	1891	growth	T042	C1155901